TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage
Key facts
- Who runs it
- Xuanwu Hospital, Beijing
- Where
- China70 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 750 people, planned
- Started
- 24 Oct 2025
- Expected to end
- 1 Mar 2028
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Early Minimally Invasive Surgery with Thrombolysis (eMIST)
- Record updated
- 20 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 24 criteriaShow less
Who can take part
- Age ≥ 18 years
- Pre-randomization head CT demonstrating an acute, spontaneous, primary ICH
- ICH volume ≥ 20mL as calculated by the ABC/2 method
- The randomization can be completed within 8 hours after the onset of stroke symptoms (or the time last known to be well), and study intervention can reasonably be initiated within 4 hours after randomization
- Historical Modified Rankin Score 0 or 1
- Obtain informed consent from patient or legal representative
Who cannot take part
- Use of 2 or more antithrombotic drugs prior to symptom onset
- Any concurrent serious illness that would interfere with the outcome assessments including hepatic, renal, gastroenterologic, respiratory, cardiovascular, endocrinologic, immunologic, and hematologic disease
- Participation in a concurrent interventional medical investigation or clinical trial
- Infratentorial intraparenchymal hemorrhage including midbrain, pontine, or cerebellar
- Ruptured aneurysm, arteriovenous malformation (AVM), vascular anomaly, Moyamoya disease, venous sinus thrombosis, mass or tumor, hemorrhagic conversion of an ischemic infarct, tumor stroke, recurrence of a recent (<1 year) ICH, as diagnosed with radiographic imaging
- Hemorrhage with apparent midbrain extension with third nerve palsy or dilated and non-reactive pupils. Other (supranuclear) gaze abnormalities are not exclusions
- Intraventricular extension of the Hemorrhage is visually estimated to involve >50% of either of the lateral ventricles
- Any irreversible coagulopathy or known clotting disorder
- Patients with a mechanical heart valve
- Urokinase allergy
- Platelet count < 750,000, INR > 1.4 after correction
- Positive urine or serum pregnancy test in female subjects without documented history of surgical sterilization or is post-menopausal
- Presence of spot sign in CT angiography
- Blood pressure control before randomization is ineffective, systolic blood pressure > 220 mmHg
- Irreversible impaired brain stem function (bilateral fixed, dilated pupils and extensor motor posturing), GCS ≤ 4
- Patients requiring long-term anti-coagulation that needs to be initiated < 30 days from index ICH
- Inability or unwillingness of patient or legal representative to give written informed consent
- Known life-expectancy of less than 6 months
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
TIME-ICH (TrIal of early Minimally Invasive catheter Evacuation with thrombolysis in IntraCerebral Hemorrhage) is a multicenter, randomized, adaptive clinical trial comparing best medical management to early minimally invasive surgery with thrombolysis (eMIST) in the treatment of acute spontaneous supratentorial intracerebral hemorrhage.
The 2 groups in the trial
- Early Minimally Invasive Surgery with Thrombolysis (eMIST) plus best medical management (BMM)Treatment being tested
Subjects will undergo minimally invasive catheter evacuation followed by up to 10 doses of 50000U of urokinase for intracerebral hemorrhage clot resolution.
Treatment: Early Minimally Invasive Surgery with Thrombolysis (eMIST)
- Best medical management (BMM)No study treatment, for comparison
Subjects will receive standard of care medical management for ICH.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage (TIME-ICH): A Prospective, Multi-center, Open-label, Adaptive, Randomized Controlled Trial
- Record updated
- 20 October 2026